Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Loopback Analytics Collaborates with University of Michigan Health on Specialty Pharmacy Initiatives

Loopback Analytics, a leading provider of data-driven solutions for hospitals and health systems, is thrilled to announce it is collaborating with University of Michigan Health to continue advancing their specialty pharmacy services.

University of Michigan Health will leverage Loopback’s data analytics platform for our growing specialty pharmacy program,” says Brandon Harkonen, Assistant Director of Specialty Pharmacy Services at University of Michigan Health. “We plan to use the Loopback platform for access to data insights that will help us improve patient care and access to life-saving medications.”

Recommended AI News: Infoworks Replicator Dramatically Accelerates On-Premises Hadoop Data Migration to the Cloud

Related Posts
1 of 40,263

Specialty pharmacy is an increasingly important aspect of health care and academic medical centers such as Michigan Medicine play a significant role in providing effective care and support for their patients. The Loopback platform will enable this effort through its easy-to-use analytics and seamless data integration.

“We are delighted to work alongside a prestigious organization like University of Michigan Health to accelerate their specialty pharmacy growth and patient care with our data analytics,” said Neil Smiley, Loopback Analytics CEO.

Recommended AI News: Onix Launches New, Customer-Centric Website

[To share your insights with us, please write to]

Comments are closed.